Ranjita Pallavi
AHN Cancer Institute-Med Onc & Infusions - Robinson
Office (412) 325-5500
Fax (412) 489-8050
6600 Steubenville Pike,THREE ROBINSON PLAZA
Suite 430
Pittsburgh, PA 15205
About
Ranjita Pallavi
Dr. Pallavi is a medical oncologist specializing in solid tumors including breast and colorectal malignancies (cancer). She sees patients with benign hematologic conditions. She provides patients with advanced chemotherapy and other medications to give them the best possible results and a high quality of life. Dr. Pallavi received a medical degree from K.J. Somaiya Medical College and Research Center in Mumbai, India. She completed two residencies, one at New York Medical College and Metropolitan Hospital Center in New York City, New York and the other in internal medicine from Grant Medical College and Sir JJ group of hospitals Mumbai, India. She gained further training through a fellowship in hematology and oncology at Westchester Medical Center in Valhalla, New York. Dr. Pallavi is board-certified in Hematology and Oncology. She speaks English and Hindi.
Primary Specialty
Hematologist
Practice
AHN Cancer Institute-Med Onc & Infusions - Robinson
Gender
Female
Education
KJ Somaiya Medical College and Research Centre Maharashtra University of Health Sciences
Training
New York Medical College, New York Medical College
Certification
American Board of Internal Medicine-Medical Oncology, American Board of Internal Medicine-Hematology
Accepting New Patients
Degrees
Medical Doctor
Admitting Hospitals
Wexford Hospital, Allegheny General Hospital, Canonsburg Hospital, West Penn Hospital, Jefferson Hospital, Forbes Hospital
Office Name
AHN Cancer Institute-Med Onc & Infusions - Robinson
Languages
Hindi, English
Business Hours
Monday:10:00 AM - 4:00 PM
Tuesday:10:00 AM - 4:00 PM
Wednesday:10:00 AM - 4:00 PM
Thursday:10:00 AM - 4:00 PM
Friday:10:00 AM - 4:00 PM
Saturday:Closed
Sunday:Closed
Services
lymphedema physical therapy, chemotherapy iv infusion, rectal neuroendocrine tumor, neuroendocrine carcinoma, metastatic neuroendocrine tumors, relapsed myeloma, colon adenocarcinoma, neutrophilia, elevated transferrin saturation, elevated ferritin, upper extremity lymphedema, large cell neuroendocrine tumors, metastatic blood cancers, neuroendocrine tumor of the lung, generalized lymphatic anomaly, adenocarcinoma of the bladder, hormone receptor negative breast cancer, nut carcinoma, fibrolamellar carcinoma, ductal carcinoma in situ (dcis), personal history of cancer, secondary cancer screening, long term side effects of cancer treatment, personal history of radiation therapy, personal history of chemotherapy, blood cancer chemotherapy, autoimmune neutropenia (ain), evans syndrome, hemophilia inhibitors, factor thirteen deficiency, factor seven deficiency, hereditary elliptocytosis (he), acquired elliptocytosis, prostate cancer chemotherapy, bladder cancer chemotherapy, testicular cancer chemotherapy, relapsed acute myelogenous leukemia (aml), adolescent and young adult cancer (aya), breast cancer biological targeted therapy, relapsed non hodgkin lymphoma, relapsed hodgkin lymphoma, relapsed acute lymphoblastic leukemia (all), neutrophil disorders, blastic plasmacytoid dendritic cell neoplasm, disseminated intravascular coagulation, hormone receptor positive breast cancer, her2 positive breast cancer, carcinoma of unknown primary, lymphomatoid granulomatosis, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, er negative breast cancer, pituitary cancer, chronic myelomonocytic leukemia, malignant adnexal tumor, peripheral t cell lymphoma, intraarterial chemotherapy of tumors, inflammatory breast cancer, recurrent breast cancer, brain metastases, coagulation disorders, bone marrow failure syndromes, waldenstrom macroglobulinemia, liver metastases, adrenal nodules, metastatic breast cancer, hodgkin lymphoma, triple negative breast cancer, cancer genetics, hemoglobinopathies, breast cancer therapy, thrombocytosis, castleman's disease, acute blood loss anemia, blood disorders, lymphopenia, prostate cancer, early detection of cancer, von willebrand disease, adenocarcinoma of lung, acute myelogenous leukemia (aml), acute lymphoblastic leukemia (all), abdominal chemotherapy, breast cancer, multiple endocrine neoplasia type 2b, multiple endocrine neoplasia type 2a, multiple endocrine neoplasia type 2, multiple endocrine neoplasia type 1, papillary cancer of thyroid, medullary cancer of thyroid, follicular cancer of thyroid, poems syndrome, recurrent cervical cancer, squamous cancer of the lung, esophageal cancer, kasabach merritt phenomenon (kmp), anemia of chronic disease
Additional Services
Oncologist